Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56

Recall Number: D-0984-2017

Firm: Teva Pharmaceuticals USA

Classification: Class III

Status: Terminated

Report Date: 20170726

Initiation Date: 20170629

Termination Date: 20180426

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.

Product Description

Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56